BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2406907)

  • 1. A critical reappraisal of the bleeding time.
    Rodgers RP; Levin J
    Semin Thromb Hemost; 1990 Jan; 16(1):1-20. PubMed ID: 2406907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time.
    Gerrard JM; Docherty JC; Israels SJ; Cheang MS; Bishop AJ; Kobrinsky NL; Schroeder ML; Israels ED
    Clin Invest Med; 1989 Jun; 12(3):165-71. PubMed ID: 2787219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans.
    Samra SK; Harrison RL; Bee DE; Valero V
    Ann Clin Lab Sci; 1991; 21(5):315-27. PubMed ID: 1952780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.
    Harrison P
    Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction.
    Jámbor C; Weber CF; Gerhardt K; Dietrich W; Spannagl M; Heindl B; Zwissler B
    Anesth Analg; 2009 Jul; 109(1):25-31. PubMed ID: 19439684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and problems of platelet function tests].
    Watanabe K; Ono F
    Rinsho Byori; 1992 May; 40(5):507-14. PubMed ID: 1507476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An in vitro bleeding test--a sensitive method for detection of disorders of platelet function in thrombocyte donors].
    Dietrich G; Kretschmer V; Schikor B; Söhngen D
    Beitr Infusionsther; 1990; 26():142-6. PubMed ID: 1703814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The platelet function analyzer (PFA-100): an update on its clinical use.
    Franchini M
    Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild bleeding disorders. A clinical and laboratory study.
    Parkin JD; Smith IL; O'Neill AI; Ibrahim KM; Butcher LA
    Med J Aust; 1992 May; 156(9):614-7. PubMed ID: 1625614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function testing to assess effectiveness of platelet transfusion therapy.
    Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
    Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of platelet dysfunction and abnormal coagulation: results of a population-based study.
    Marxsen JH; Forchheim S; Zuske-Matthäus A; Wagner T
    Clin Appl Thromb Hemost; 2009; 15(4):421-7. PubMed ID: 18387983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of massive operative blood loss.
    Kozek-Langenecker S
    Minerva Anestesiol; 2007; 73(7-8):401-15. PubMed ID: 17380100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation of the bleeding patient.
    Sirridge M
    Clin Lab Med; 1984 Jun; 4(2):285-301. PubMed ID: 6499398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet dysfunction in outpatients with left ventricular assist devices.
    Steinlechner B; Dworschak M; Birkenberg B; Duris M; Zeidler P; Fischer H; Milosevic L; Wieselthaler G; Wolner E; Quehenberger P; Jilma B
    Ann Thorac Surg; 2009 Jan; 87(1):131-7. PubMed ID: 19101285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged bleeding time in children and young adults with hemophilia.
    Buchanan GR; Holtkamp CA
    Pediatrics; 1980 Dec; 66(6):951-5. PubMed ID: 7454486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical usefulness of the preoperative bleeding time.
    Gewirtz AS; Miller ML; Keys TF
    Arch Pathol Lab Med; 1996 Apr; 120(4):353-6. PubMed ID: 8619746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.